About TBMC

The rapid progress, production, and global distribution of mRNA vaccines have played a pivotal role in combating the effects of COVID-19 worldwide. In the early stages of vaccine rollout, the supply of mRNA vaccines was primarily directed to the countries engaged in their development and production, leading to a temporary shortage of vaccines in Taiwan.
Consequently, a country‘s ability to quickly manufacture advanced biological pharmaceuticals through Contract Development and Manufacturing Organization (CDMO) services is closely linked to protecting the health and welfare of its citizens.
Taiwan Bio-Manufacturing Corporation (TBMC), established in May 2023, specializes in cutting-edge biotechnology, including Gene Therapy, cell therapies, and protein technologies. Born from collaborations with the Department Center for Biotechnology (DCB) and Industrial Technology Research Institute (ITRI), TBMC is rapidly advancing in biopharmaceutical manufacturing.
With state-of-the-art technologies like Raman spectroscopy and automated cell culturing system, TBMC aims to become Asia's first Pharma 4.0 CDMO, delivering high-quality biologics medicines.
Previous
Next
Vision
At TBMC, our vision is to become a world-class bio-manufacturing CRDMO, recognized for innovation, reliability, agility, and efficiency. We proudly operate by our guiding principle of unwavering competitiveness, consistency and commitment. We are dedicated to building an inspired team by hiring only the best talent and fostering a culture of continuous motivation and excellence.
Mission
Our mission is to manufacture advanced biopharmaceuticals using cutting-edge technologies that deliver maximum efficiency, speed, yield, and production success. We are committed to bringing the highest standards of biomanufacturing to our partners and the patients they serve.
Previous
Next
We believe true success lies in the disciplined execution of six key pillars:

Customer satisfaction and trust

Technical Prowess

Global Reach

Engrained End-to-End Quality

Strong Leadership and Engaged Workforce

Culture of Accountability and Execution

These principles strengthen our competitiveness, elevate us to world-class standards, and enable us to lead and create value to the global biomanufacturing industry.
TBMC典範複製_英文版__new
TBMC典範複製_英文版__new2
Previous
Next

Milestone

Process Development Lab
Operational since 2024 Q2

Taipei Bioinnovation Park

1,820 m2

Cell Therapy Process Development Lab
Operational since 2024 Q4

GMP Plant
Operational Ready by 2026 Q2

Hsinchu Biomedical Science Park
11,900 m2

Process Development Lab
Operational since 2024 Q2

Taipei Bioinnovation Park

1,820 m2

Cell Therapy Process Development Lab
Operational since 2024 Q4

GMP Plant
Operational Ready by 2026 Q2

Hsinchu Biomedical Science Park
11,900 m2

Team